Get Protara Therapeutics Inc (TARA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Protara Therapeutics, Inc. is a clinical-stage company engages in developing treatments for rare and specialty diseases with significant unmet needs. Stocks Rankings for TARA.

2021-03-25 · Protara Therapeutics Company Profile. Protara Therapeutics, Inc, a clinical-stage company, engages in the identifying and advancing transformative therapies for people with rare and specialty diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire Sep 02, 2020 Protara Therapeutics Announces Second Quarter 2020 Financial Results and 2021-04-06 · Protara Therapeutics. stock was originally listed at a price of $401.20 in Oct 22, 2014. If you had invested in Protara Therapeutics stock at $401.20, your return over the last 6 years would have been -96.22%, for an annualized return of -42.06%. 2020-10-02 · View the latest Protara Therapeutics Inc. (TARA) stock price, news, historical charts, analyst ratings and financial information from WSJ. Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases.

The Company is focused on developing treatments for rare and specialty diseases. Its development programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology/gastrointestinal and metabolic disorders. Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatment options. 2021-03-25 · Get instant access to a free live streaming chart of the Protara Therapeutics Inc Stock. The chart is intuitive yet powerful, offering users multiple chart types including candlesticks, area 2020-09-22 · NEW YORK, Sept.

TARA stock forecast Our latest prediction for Protara Therapeutics Inc's stock price was made on the Sept. 30, 2020 when the stock price was at 16.83$.. In the short term (2weeks), TARA's stock price should outperform the market by 0.66%.During that period the price should oscillate between -11.58% and +18.21%.. In the medium term (3months), TARA's stock price should underperform the market by

Renaissance Technologies LLC owned approximately 0.15% of […] Protara Therapeutics, Inc. is a clinical-stage company engages in developing treatments for rare and specialty diseases with significant unmet needs. Its current development programs focus on the treatment of rare diseases in structural and connective tissues and rare hepatology, gastrointestinal, and metabolic disorders. 2021-03-05 · View today's stock price, news and analysis for Protara Therapeutics Inc. (TARA).

2 Jun 2020 That average ranking earns TARA an Analyst Rating of 80, which is better than 80% of stocks based on data compiled by InvestorsObserver.

Wall Street Stock Market & Finance report, prediction for the future: You'll find the Protara Therapeutics share forecasts, stock quote and buy / sell signals below.According to present data Protara Therapeutics's TARA shares and potentially its market environment have been in bearish cycle Protara Therapeutics, Inc. 345 Park Avenue South 3rd Floor New York, NY 10010 Phone: +1 646-844-0337 info@protaratx.com 2021-04-09 Protara Therapeutics, Inc. 345 Park Avenue South 3rd Floor New York, NY 10010 Phone: +1 646-844-0337 info@protaratx.com Protara Therapeutics, Inc. Common Stock (TARA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Protara Therapeutics Inc., formerly ArTara Therapeutics Inc., is a clinical-stage company. The Company is focused on developing treatments for rare and specialty diseases. Its development programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology/gastrointestinal and metabolic disorders.

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatment options. 2021-03-25 2021-03-23 Which company executives are buying and selling shares of Protara Therapeutics (NASDAQ:TARA) stock? View the most recent insider trading activity for TARA stock at MarketBeat. S&P 500 4,128.80. DOW 33,800.60.
Olika handstilar

{{ portfolio. portfolio_name }}; You have no watchlists at this time, click Protara Therapeutics | 1040 followers on LinkedIn. Steadfast and tenacious in Company size: 11-50 employees Contract Recruiter at Protara Therapeutics.

08:25 AM ET. Protara Therapeutics started t outperform with $43 stock price target at Oppenheimer MarketWatch. Wednesday, January 22, 2020. 07:48 AM ET. ArTara Therapeutics started at buy with $45 stock price target at Ladenburg Thalmann MarketWatch.
Vårdcentralen åtvidaberg tel nr

bra värvning
silica fume concrete
medicincentrum norrlands universitetssjukhus
scott stomierowski
mynewsdesk lidköping

Stock quote and company snapshot for PROTARA THERAPEUTICS INC (TARA), including profile, stock chart, recent news and events, analyst opinions, and

Current price today: ▽14.100 USD Protara Therapeutics historical price data and TARA charts. Free real-time prices, Market, Type. Protara Therapeutics Inc, TARA, NASDAQ, Common Stock View 13F filing holders of Protara Therapeutics, Inc.. Ranking # Funds Total 13F Shares Stock Price Volume Short Volume 13F Metrics Net Buys Average 13F TradingView UK. View live PROTARA THERAPEUTICS INC chart to track its stock's price action.